Implantable cardioverter defibrillator in high-rist long QT Syndrome patients

被引:185
作者
Zareba, W
Moss, AJ
Daubert, JP
Hall, WJ
Robinson, JL
Andrews, M
机构
[1] Univ Rochester, Sch Med & Dent, Cardiol Unit, Dept Med, Rochester, NY USA
[2] Univ Rochester, Sch Med & Dent, Dept Biostat, Rochester, NY USA
关键词
long QT syndrome; death sudden; defibrillation; prognosis;
D O I
10.1046/j.1540-8167.2003.02545.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ICD in High-Risk LQTS Patients. Introduction: Implantable cardioverter defibrillators (ICDs) are increasingly being used in high-risk long QT syndrome (LQTS) patients, but there are limited data regarding clinical experience with this therapeutic modality. The aim of this study is to describe the clinical characteristics of 125 LQTS patients treated with ICDs compared with LQTS patients having similar risk indications who were not treated with ICDs. Methods and Results: Among 125 LQTS patients with ICDs, there were 54 cardiac arrest survivors, 19 patients who had ICDs implanted due to recurrent syncope despite beta-blocker therapy, and 52 patients with ICDs implanted due to other reasons, including syncope and LQTS-related sudden death in a close family member. Patients with cardiac arrest and those with recurrent syncope despite beta-blocker therapy (n = 73) were compared to 161 LQTS patients who had similar indications (89 cardiac arrest and 72 recurrent syncope despite beta-blocker therapy) but did not receive ICDs. Total mortality was the endpoint of the analysis. There was 1 (1.3%) death in 73 ICD patients followed an average of 3 years, whereas there were 26 deaths (16%) in non-ICD patients during mean 8-year follow-up (P = 0.07 from log rank test from Kaplan-Meier curves). Conclusion: ICDs provide an important therapeutic option to prevent sudden arrhythmic death in high-risk LQTS patients. A long-term prospective study is needed to determine the benefit of this therapeutic modality in LQTS patients.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 21 条
[1]   IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH ARRHYTHMOGENIC RIGHT-VENTRICULAR CARDIOMYOPATHY, LONG QT SYNDROME, OR NO STRUCTURAL HEART-DISEASE [J].
BREITHARDT, G ;
WICHTER, T ;
HAVERKAMP, W ;
BORGGREFE, M ;
BLOCK, M ;
HAMMEL, D ;
SCHELD, HH .
AMERICAN HEART JOURNAL, 1994, 127 (04) :1151-1158
[2]   Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death [J].
Brugada, J ;
Brugada, R ;
Brugada, P .
JOURNAL OF ELECTROCARDIOLOGY, 2000, 33 :41-47
[3]   Long-term follow-up of patients with long-QT syndrome treated with β-blockers and continuous pacing [J].
Dorostkar, PC ;
Eldar, M ;
Belhassen, B ;
Scheinman, MM .
CIRCULATION, 1999, 100 (24) :2431-2436
[4]   Use of implantable cardioverter-defibrillators in the congenital long QT syndrome [J].
Groh, WJ ;
Silka, MJ ;
Oliver, RP ;
Halperin, BD ;
McAnulty, JH ;
Kron, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (06) :703-706
[5]   Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome - Findings from the international LQTS registry [J].
Locati, EH ;
Zareba, W ;
Moss, AJ ;
Schwartz, PJ ;
Vincent, GM ;
Lehmann, MH ;
Towbin, JA ;
Priori, SG ;
Napolitano, C ;
Robinson, JL ;
Andrews, M ;
Timothy, K ;
Hall, WJ .
CIRCULATION, 1998, 97 (22) :2237-2244
[6]   Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. [J].
Maron, BJ ;
Shen, WK ;
Link, MS ;
Epstein, AE ;
Almquist, AK ;
Daubert, JP ;
Bardy, GH ;
Favale, S ;
Rea, RF ;
Boriani, G ;
Estes, NAM ;
Spirito, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :365-373
[7]   EFFICACY OF PERMANENT PACING IN THE MANAGEMENT OF HIGH-RISK PATIENTS WITH LONG QT SYNDROME [J].
MOSS, AJ ;
LIU, JE ;
GOTTLIEB, S ;
LOCATI, EH ;
SCHWARTZ, PJ ;
ROBINSON, JL .
CIRCULATION, 1991, 84 (04) :1524-1529
[8]   Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel [J].
Moss, AJ ;
Zareba, W ;
Kaufman, ES ;
Gartman, E ;
Peterson, DR ;
Benhorin, J ;
Towbin, JA ;
Keating, MT ;
Priori, SG ;
Schwartz, PJ ;
Vincent, GM ;
Robinson, JL ;
Andrews, ML ;
Feng, CY ;
Hall, WJ ;
Medina, A ;
Zhang, L ;
Wang, ZQ .
CIRCULATION, 2002, 105 (07) :794-799
[9]   THE LONG QT SYNDROME - PROSPECTIVE LONGITUDINAL-STUDY OF 328 FAMILIES [J].
MOSS, AJ ;
SCHWARTZ, PJ ;
CRAMPTON, RS ;
TZIVONI, D ;
LOCATI, EH ;
MACCLUER, J ;
HALL, WJ ;
WEITKAMP, L ;
VINCENT, GM ;
GARSON, A ;
ROBINSON, JL ;
BENHORIN, J ;
CHOI, SS .
CIRCULATION, 1991, 84 (03) :1136-1144
[10]   Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome [J].
Moss, AJ ;
Zareba, W ;
Hall, WJ ;
Schwartz, PJ ;
Crampton, RS ;
Benhorin, J ;
Vincent, GM ;
Locati, EH ;
Priori, SG ;
Napolitano, C ;
Medina, A ;
Zhang, L ;
Robinson, JL ;
Timothy, K ;
Towbin, JA ;
Andrews, ML .
CIRCULATION, 2000, 101 (06) :616-623